Willow Biosciences (WLLW.T) started its pilot production run to deliver of inaugural samples of its cannabinoid, cannabigerol (CBG) product in Q3, 2020. In case you’re not entirely down on…
cannabigerol
“Visual confirmation of test results (probe activation) was observed in five to seven minutes,” states Xphyto….
Our early coverage of Xphyto reveals the following company trait: Xphyto says, “We’re going to do this” – and then they do it – quickly….
Vektor is now proceeding with process implementation for the manufacture of Rotigotine patches for human clinical studies….
Xphyto Therapeutics (XPHY.C) German subsidiary Vektor Pharma TF GmbH will commence several research and development programs related to infectious disease, including thin film delivery of cannabigerol (CBG) and quercetic…
Cannabics Pharmaceuticals (CNBX.OTC) announced that its recent tests have shown that the cannabinoids CBC (cannabichromene) and CBD (cannabigerol) both exhibit anti-tumour properties when tested on human gastrointestinal cancer cells….